We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How to spot lumpy skin disease, what to do if you suspect it and how to prevent it spreading.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
The review of the safety of isotretinoin has concluded.
Information for healthcare professionals to protect the public from pressure ulcers (bed sores).
Check what you need to do to sell cosmetic products in Great Britain.
Current issues relating to imports and exports of animals and animal products.
Product Safety Report for RODIS Creme Skin Light presenting a serious chemical risk due to the presence of the skin sensitiser hydroquinone.
Public Assessment Report (PAR) reviewing available safety data for topical steroid withdrawal reactions, which have been associated with topical corticosteroids.
Product Safety Report for GDK Akagni Skin Toning Cream presenting a serious chemical risk.
Find out how the Prevent programme supports people who are at risk of becoming involved with terrorism through radicalisation.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
Photosensitivity reactions are known side effects of methotrexate treatment and can be severe. Patients should be advised to take precautions to protect their skin in the sun.
Product Safety Report for Skin Gard Lightening Lotion presenting a serious chemical risk.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).